These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38813441)

  • 1. Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT recruitment intervention (QRI).
    Wade J; Farrar N; Realpe AX; Donovan JL; Forsyth L; Harkness KA; Hutchinson PJA; Kitchen N; Lewis SC; Loan JJM; Stephen J; Al-Shahi Salman R;
    EClinicalMedicine; 2024 May; 71():102557. PubMed ID: 38813441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial.
    CARE pilot trial collaboration
    Lancet Neurol; 2024 Jun; 23(6):565-576. PubMed ID: 38643777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of comparing medical management and surgery (with neurosurgery or stereotactic radiosurgery) with medical management alone in people with symptomatic brain cavernoma - protocol for the Cavernomas: A Randomised Effectiveness (CARE) pilot trial.
    Loan JJM; Bacon A; van Beijnum J; Bhatt P; Bjornson A; Broomes N; Bullen A; Bulters D; Cahill J; Chavredakis E; Colombo F; Danciut M; Digpal R; Edwards RJ; Ferguson L; Forsyth L; Fouyas I; Ganesan V; Grover P; Gurusinghe N; Hall PS; Harkness K; Harris LS; Hayton T; Helmy A; Holsgrove D; Hutchinson PJ; Israni A; Kinsella E; Lewis S; Majeed S; Mallucci C; Mukerji N; Nair R; Neilson AR; Papadopoulos MC; Radatz M; Rossdeutsch A; Raza-Knight S; Stephen J; Stoddart A; Teo M; Turner C; Wade J; Walsh D; White D; White P; Wildman J; Wroe Wright O; Uff C; Ushewokunze S; Vindlacheruvu R; Kitchen N; Al-Shahi Salman R;
    BMJ Open; 2023 Aug; 13(8):e075187. PubMed ID: 37558454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising recruitment to the HAND-1 RCT feasibility study: integration of the QuinteT Recruitment Intervention (QRI).
    Husbands S; Elliott D; Davis TRC; Blazeby JM; Harrison EF; Montgomery AA; Sprange K; Duley L; Karantana A; Hollingworth W; Mills N
    Pilot Feasibility Stud; 2020 Nov; 6(1):173. PubMed ID: 33292646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a new adapted QuinteT Recruitment Intervention (QRI-Two) for rapid application to RCTs underway with enrolment shortfalls-to identify previously hidden barriers and improve recruitment.
    Donovan JL; Jepson M; Rooshenas L; Paramasivan S; Mills N; Elliott D; Wade J; Reda D; Blazeby JM; Moghanaki D; Hwang ES; Davies L
    Trials; 2022 Apr; 23(1):258. PubMed ID: 35379301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative behavioural intervention to reduce drinking before elective orthopaedic surgery: the PRE-OP BIRDS feasibility RCT.
    Snowden C; Lynch E; Avery L; Haighton C; Howel D; Mamasoula V; Gilvarry E; McColl E; Prentis J; Gerrand C; Steel A; Goudie N; Howe N; Kaner E
    Health Technol Assess; 2020 Mar; 24(12):1-176. PubMed ID: 32131964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to address recruitment to a randomised trial of surgical and non-surgical treatment for cancer: results from a complex recruitment intervention within the Mesothelioma and Radical Surgery 2 (MARS 2) study.
    Mills N; Farrar N; Warnes B; Ashton KE; Harris R; Rogers CA; Lim E; Elliott D
    BMJ Open; 2024 May; 14(5):e079108. PubMed ID: 38760029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
    Wilson C; Rooshenas L; Paramasivan S; Elliott D; Jepson M; Strong S; Birtle A; Beard DJ; Halliday A; Hamdy FC; Lewis R; Metcalfe C; Rogers CA; Stein RC; Blazeby JM; Donovan JL
    Trials; 2018 Jan; 19(1):50. PubMed ID: 29351790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer.
    Elliott D; Hamdy FC; Leslie TA; Rosario D; Dudderidge T; Hindley R; Emberton M; Brewster S; Sooriakumaran P; Catto JWF; Emara A; Ahmed H; Whybrow P; le Conte S; Donovan JL
    BJU Int; 2018 Dec; 122(6):970-977. PubMed ID: 29888845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer.
    Conefrey C; Donovan JL; Stein RC; Paramasivan S; Marshall A; Bartlett J; Cameron D; Campbell A; Dunn J; Earl H; Hall P; Harmer V; Hughes-Davies L; Macpherson I; Makris A; Morgan A; Pinder S; Poole C; Rea D; Rooshenas L;
    Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):382-389. PubMed ID: 32089356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI).
    Donovan JL; Rooshenas L; Jepson M; Elliott D; Wade J; Avery K; Mills N; Wilson C; Paramasivan S; Blazeby JM
    Trials; 2016 Jun; 17(1):283. PubMed ID: 27278130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
    Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
    Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation.
    Rooshenas L; Scott LJ; Blazeby JM; Rogers CA; Tilling KM; Husbands S; Conefrey C; Mills N; Stein RC; Metcalfe C; Carr AJ; Beard DJ; Davis T; Paramasivan S; Jepson M; Avery K; Elliott D; Wilson C; Donovan JL; ; ; ; ;
    J Clin Epidemiol; 2019 Feb; 106():108-120. PubMed ID: 30339938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative treatment for uncomplicated appendicitis in children: the CONTRACT feasibility study, including feasibility RCT.
    Hall NJ; Sherratt FC; Eaton S; Reading I; Walker E; Chorozoglou M; Beasant L; Wood W; Stanton M; Corbett HJ; Rex D; Hutchings N; Dixon E; Grist S; Hoff WV; Crawley E; Blazeby J; Young B
    Health Technol Assess; 2021 Feb; 25(10):1-192. PubMed ID: 33630732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study.
    McDermott C; Vennik J; Philpott C; le Conte S; Thomas M; Eyles C; Little P; Blackshaw H; Schilder A; Hopkins C
    Trials; 2021 Jan; 22(1):54. PubMed ID: 33436031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualised placement and support programme for people unemployed because of chronic pain: a feasibility study and the InSTEP pilot RCT.
    Linaker C; Fraser S; Price C; Maguire N; Little P; Madan I; Pinedo-Villanueva R; Coggon D; Cooper C; Ntani G; Walker-Bone K
    Health Technol Assess; 2021 Jan; 25(5):1-72. PubMed ID: 33501902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial.
    Lanfranconi S; Scola E; Meessen JMTA; Pallini R; Bertani GA; Al-Shahi Salman R; Dejana E; Latini R;
    Lancet Neurol; 2023 Jan; 22(1):35-44. PubMed ID: 36403580
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.